In addition to transcription activity, PLAGL2 was found to promote tumor progression by regulating actin cytoskeletal architecture, or facilitating p53 degradation via binding and stabilizing Pirh2, an E3 ubiquitin ligase for p5341,42. Here, RCHY1 is linked to neoplasm.